CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Oxford Technology Venture Cptl Trust PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Oxford Technology Venture Cptl Trust PLC
Magdalen Centre, Oxford Scienc
Phone: +44 1865784466p:+44 1865784466 OXFORD, OX4 4GA  United Kingdom Ticker: OXTOXT
This company was Merged or Acquired on 7/25/2022.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Oxford Technology Venture Capital Trust Plc is a United Kingdom-based venture capital trust (VCT). The Company focuses on investing in early stage and start-up technology companies. It has holdings in four companies, namely Arecor Therapeutics Plc (Arecor), BioCote Ltd (BioCote), Getmapping Plc, Scancell Holdings Plc (Scancell) and STL Management Limited (Select Technology). The Company's subsidiary OT1 Managers Ltd helps to provides investment management services to the Company. Arecor is a biopharmaceutical company that focuses on delivering enhanced reformulations of its partner's therapeutic products. BioCote is engaged in supplying the material, formulated for the needs of each customer, and the coating is then applied in the customers' factories, which is anti-microbial. Scancell is focused on developing immunotherapies for cancer that stimulate the body’s own immune system. Select Technology specializes in software for photocopiers known as Multi-Function Devices (MFDs).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
8/31/20212/28/2021Yes----

Industries
SIC Code Description
6726 Unit investment trusts, face-amount certificate offices

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board AlexStarling 43 7/31/2014 7/31/2014
Secretary James D.Gordon
Non-Executive Director Robin M.Goodfellow 74 7/3/2015 7/3/2015
Non-Executive Director DavidLivesley 60 7/3/2015 7/3/2015
Non-Executive Director RichardRoth 57 7/31/2014 7/31/2014

General Information
Outstanding Shares: 5,431,655 (As of 6/16/2022)
Shareholders: 6,756
Stock Exchange: LON
Fax Number: +44 1865784430


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 16, 2024